Sophia Genetics SA - Asset Resilience Ratio
Sophia Genetics SA (SOPH) has an Asset Resilience Ratio of 0.00% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Sophia Genetics SA strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2018–2023)
This chart shows how Sophia Genetics SA's Asset Resilience Ratio has changed over time. See debt-free asset ratio of Sophia Genetics SA to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Sophia Genetics SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Sophia Genetics SA worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Sophia Genetics SA maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Sophia Genetics SA Industry Peers by Asset Resilience Ratio
Compare Sophia Genetics SA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Waystar Holding Corp. Common Stock
NASDAQ:WAY |
Health Information Services | 2.13% |
|
Oneview Healthcare Plc
AU:ONE |
Health Information Services | 29.71% |
|
Forian Inc
NASDAQ:FORA |
Health Information Services | 42.25% |
|
Intrasense
PA:ALINS |
Health Information Services | 15.68% |
|
Pro Medicus Ltd
AU:PME |
Health Information Services | 54.64% |
|
Echoiq Ltd
AU:EIQ |
Health Information Services | 11.12% |
|
ARTRYA Ltd
AU:AYA |
Health Information Services | 32.70% |
|
Cogstate Ltd
AU:CGS |
Health Information Services | 54.90% |
Annual Asset Resilience Ratio for Sophia Genetics SA (2018–2023)
The table below shows the annual Asset Resilience Ratio data for Sophia Genetics SA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 0.00% | $0.00 | $206.16 Million | -- |
| 2022-12-31 | 7.10% | $17.31 Million | $243.84 Million | -15.50pp |
| 2021-12-31 | 22.60% | $72.36 Million | $320.17 Million | +5.40pp |
| 2020-12-31 | 17.20% | $22.72 Million | $132.12 Million | +16.49pp |
| 2019-12-31 | 0.71% | $366.00K | $51.66 Million | +0.17pp |
| 2018-12-31 | 0.54% | $413.00K | $76.62 Million | -- |
About Sophia Genetics SA
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutic… Read more